projects
| title | type of... | start | status | ||
| BMS_IM101-863 | clinical studies | 2022 | scheduled | ||
| AbbVie UPSTAND P20-410 SLEESPA | clinical studies | 2021 | ongoing - rec... | ||
| Abbvie UPHOLD P20-095 SLEERA | clinical studies | 2020 | ongoing - fol... | ||
| I4V-MC-JAIM | clinical studies | 2020 | ongoing - fol... | ||
| CAIN457Q12301 | clinical studies | 2020 | ongoing - rec... | ||
| IgPro20_3007: RECLAIM | clinical studies | 2020 | ongoing - rec... | ||
| RA Bridge | clinical studies | 2019 | ongoing - fol... | ||
| Amgen CC-10004-PsA-014 MOSAIK | clinical studies | 2019 | ongoing - rec... | ||
| Sanofi GCA EFC15068 | clinical studies | 2019 | aborted | ||
| Sanofi PMR EFC15160 | clinical studies | 2019 | automatically... | ||
| Abbvie M16-852 A Multicenter, Randomized, D... | clinical studies | 2019 | ongoing - rec... | ||
| Lilly JAHZ A Randomized, Double-Blind, Plac... | clinical studies | 2019 | completed | ||
| CORBUS: Lenabasum bei diffuser systemischer... | clinical studies | 2018 | aborted | ||
| Abbvie M15-925: A Phase 3, Randomized, Acti... | clinical studies | 2018 | ongoing - fol... | ||
| Skippain | clinical studies | 2018 | completed | ||
| Lilly RHCF SPIRIT | clinical studies | 2017 | completed | ||
| Abbvie M15-572 Phase 3 PsA mit inadäquater ... | clinical studies | 2017 | ongoing - fol... | ||
| Finch 302 Gilead | clinical studies | 2017 | completed | ||
